Non-interventional Study to Assess the Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma (FL)
Non-interventional Study to Assess the Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma (FL)
The primary objective of this study is to assess the overall safety profile of idelalisib monotherapy in patients with refractory follicular lymphoma (FL).
Inclusion Criteria:
Exclusion Criteria:
Rionero in Vulture, 85028, Italy
Lisbon, 1090-023, Portugal
Gipuzkoa, 20014, Spain